Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases

REFERENCES

1. 1.↵
   2. Keilholz U

   . CTLA-4: negative regulator of the immune response and a target for cancer therapy. J Immunother 2008;31:431–39 doi:10.1097/CJI.0b013e318174a4fe pmid:18463542

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Manousakis G,
   3. Koch J,
   4. Sommerville RB, et al

   . Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve 2013;48:440–44 doi:10.1002/mus.23830 pmid:23447136

   CrossRefPubMed
3. 3.↵
   2. Carpenter KJ,
   3. Murtagh RD,
   4. Lilienfeld H, et al

   . Ipilimumab-induced hypophysitis: MR imaging findings. AJNR Am J Neuroradiol 2009;30:1751–53 doi:10.3174/ajnr.A1623 pmid:19474123

   Abstract/FREE Full Text